Skip to main content

Course Information

  • ISPOR Education Center Microcourse

    Introduction to Health Technology Assessment (HTA)

    Health technology assessment (HTA) plays an important role in supporting evidence-informed healthcare decision-making. This introductory course explores the purpose of HTA, its relationship to health economics and outcomes research (HEOR), and how it brings together evidence to evaluate health technologies. Learners will examine the key domains, principles, and processes of HTA and explore how assessment findings can inform healthcare decisions. Through an HPV vaccination case study and interactive learning activities, participants will gain a foundational understanding of how HTA is applied in practice.

    After the completion of this course participants will be able to:

    • Define health technology assessment (HTA) and explain its relationship to HEOR and healthcare decision-making.
    • Identify the key domains considered in HTA and describe their relevance to evaluating health technologies.
    • Describe the guiding principles and major steps of the HTA process.
    • Explain how HTA findings can be used to inform healthcare decisions.
    • Apply foundational HTA concepts to a healthcare decision-making scenario.

    LEVEL: Introductory
    TRACK: Health Technology Assessment
    HEOR Competency: 9.1 Global Understanding of Health Systems and HTA
    HEOR Competencies: A resource for HEOR Professionals

    The access period once enrolled into the course is 30 days from the date of purchase. After this duration, you will need to re-enroll if you wish to re-enter the course.

    Time to complete – approximately 1 hour

Speakers

Speaker information is not available at this time.

Fees
  • Microcourse: Introduction to Health Technology Assessment (HTA) Non-Member: $60.00
  • Microcourse: Introduction to Health Technology Assessment (HTA) Member: $45.00

ISPOR–The Professional Society for 
Health Economics and Outcomes Research

 

Copyright © 2026 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc